Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

$850M Deal Kicks Off RNA Vaccine Research

RNA strand illustration

Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA. . . . → Read More: $850M Deal Kicks Off RNA Vaccine Research

Data Tools Designed for Genomics-Based Precision Cancer Care

Computational biology illustration

A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems. . . . → Read More: Data Tools Designed for Genomics-Based Precision Cancer Care

FDA Delays Crispr Trial for Inherited Blood Diseases

Crispr-Cas9 illustration

The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases

New ALS Drug Formula Shown Active, Safe

Neurons

A new formulation of a current drug to treat amyotrophic lateral sclerosis, or ALS, shows in its first clinical trial the drug produces more active ingredients against ALS than the current drug and causes no safety concerns. . . . → Read More: New ALS Drug Formula Shown Active, Safe

Brain Stimulation Shown to Reduce Insulin Resistance

brain stimulationgraphic

Electrical stimulation of an area in the brain that releases the hormone dopamine is shown to increase sensitivity to insulin, opening a potential new pathway for treating type 2 diabetes. . . . → Read More: Brain Stimulation Shown to Reduce Insulin Resistance

Trial Testing Gene-Edited, Modified Oilseed Plants

Camelina plant

An agricultural science lab in the U.K. is beginning research on sustainable methods for growing genome-edited camelina plants, along with modifying the plant’s genetics by adding genes from other plant species. . . . → Read More: Trial Testing Gene-Edited, Modified Oilseed Plants

Cannabis Derivative Shown to Reduce Severe Seizures

Epilepsy graphic

A clinical trial shows treatments made with cannabidiol, a medical-grade derivative of cannabis plants, reduce the number of severe seizures in people with Lennox–Gastaut syndrome, when combined with conventional drugs. . . . → Read More: Cannabis Derivative Shown to Reduce Severe Seizures

Computer-Designed Heart Valves Operate Over Long Term

Engineered heart valve

A European research team designed customized heart valves with computer models, which when tested in sheep continued to perform in most cases for a year following implantation. . . . → Read More: Computer-Designed Heart Valves Operate Over Long Term

Virtual Reality Harnessed for Stroke Rehab

Peii Chen

A rehabilitation research foundation and company specializing in immersive technologies are applying virtual reality to help treat spacial neglect, a common cognitive disability associated with stroke. . . . → Read More: Virtual Reality Harnessed for Stroke Rehab

Gene Therapy Biotech Acquired in $8.7 Billion Deal

A biotechnology enterprise developing gene therapies for rare inherited diseases and neurological disorders is being acquired by pharmaceutical company Novartis AG for $8.7 billion. . . . → Read More: Gene Therapy Biotech Acquired in $8.7 Billion Deal